Opioid maintenance patients with QTc prolongation: Congenital long QT syndrome mutation may be a contributing risk factor

Drug and Alcohol Dependence

Volumn 112, Issue 3, 2010, Pages 216-219

  Anchersen, Katinka ^a   Hansteen, Viggo ^b   Gossop, Michael ^c   Clausen, Thomas ^a   Waal, Helge ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Congenital long QT syndrome; Genetic; Management; Methadone; QT prolongation

Indexed keywords

BUPRENORPHINE; METHADONE; METOPROLOL; SELO ZOK; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EXERCISE; FEMALE; GENE MUTATION; HEART DISEASE; HEROIN DEPENDENCE; HETEROZYGOTE; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHADONE TREATMENT; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; ELECTROCARDIOGRAPHY; FEMALE; GENETIC TESTING; HETEROZYGOTE; HUMANS; LONG QT SYNDROME; MALE; METHADONE; MIDDLE AGED; MUTATION; OPIATE SUBSTITUTION TREATMENT; RISK FACTORS;

EID: 78649661829     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.06.015     Document Type: Article

References (17)

1. Anchersen K., Clausen T., Gossop M., Hansteen V., Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009, 104:993-999.
2. Berge K.E., Haugaa K.H., Fruh A., Anfinsen O.G., Gjesdal K., Siem G., Oyen N., Greve G., Carlsson A., Rognum T.O., Hallerud M., Kongsgard E., Amlie J.P., Leren T.P. Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Investig 2008, 68:362-428.
3. Chiang C.E. Congenital and acquired long QT syndrome. Current concepts and management. Cardiol Rev 2004, 12:222-234.
4. De Ferrari G.M., Schwartz P.J. Long QT syndrome, a purely electrical disease? Not anymore. Eur Heart J 2009, 30:253-255.
5. Extramiana F., Leenhardt A., Maison-Blanche P. ECG evaluation of ventricular properties: the importance of cardiac cycle length. Ann Noninvas Electrocardiol 2009, 14:S54-S59.
6. Fanoe S., Hvidt C., Ege P., Jensen G.B. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart 2007, 93:1051-1055.
7. Fonseca F., Marti-Almor J., Pastor A., Cladellas M., Farre M., de la Torre R., Torrens M. Prevalence of long QTc interval in methadone maintenance patients. Drug Alcohol Depend 2009, 99:327-332.
8. Goldenberg I., Moss A.J. Long QT syndrome. J Am Coll Cardiol 2008, 51:2291-2300.
9. Harris R.I., Steare S.E. A meta-analysis of ECG data from healthy male volunteers: diurnal and intra-subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies. Eur J Clin Pharmacol 2006, 62:893-903.
10. Hinterseer M., Beckmann B.M., Thomsen M.B., Pfeufer A., Pozza R.D., Loeff M., Netz H., Steinbeck G., Vos M.A., Kaab S. Relation of increased short-term variability of QT interval to congenital long-QT syndrome. Am J Cardiol 2009, 103:1244-1248.
11. Markiewicz-Loskot G., Moric-Janiszewska E., Mazurek U. The risk of cardiac events and genotype-based management of LQTS patients. Ann Noninvas Electrocardiol 2009, 14:86-92.
12. Napolitano C., Priori S.G., Schwartz P.J., Bloise R., Ronchetti E., Nastoli J., Bottelli G., Cerrone M., Leonardi S. Genetic testing in the long QT syndrome-development and validation of an efficient approach to genotyping in clinical practice. J Am Med Assoc 2005, 294:2975-2980.
13. Peles E., Bodner G., Kreek M.J., Rados V., Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients-a cross-sectional study. Addiction 2007, 102:289-300.
14. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., Cappelletti D. Risk stratification in the long-QT syndrome. N Engl J Med 2003, 348:1866-1874.
15. Reddy S., Hui D., El Osta B., de la Cruz M., Walker P., Palmer J.L., Bruera E. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliative Med 2010, 13:33-38.
16. Vincent G.M. Long QT syndrome. Cardiol Clin 2000, 18:309-325.
17. Wedam E.F., Bigelow G.E., Johnson R.E., Nuzzo P.A., Haigney M.C.P. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007, 167:2469-2475.